FDA Inspection 968597 — Novo Nordisk Inc.
The FDA completed an inspection of Novo Nordisk Inc. on Apr 12, 2016 in Plainsboro, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 12, 2016
- Fiscal Year
- 2016
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Plainsboro, NJ (United States)
Additional Details
Sponsor, Contract Research Organization